Loading…
chronic obstructive pulmonary disease
lung disease involving long-term poor airflow
Details
- Instance of
- type of disease
- Subclass of
- obstructive lung disease
- drug or therapy used for treatment
- (RS)-clenbuterol, indacaterol maleate, fluticasone furoate, ambroxol, indacaterol, glycopyrrolate, formoterol, erdosteine, bambuterol, L-carbocysteine, etofylline
- genetic association
- CHRNA3, FAM13A, RIN3, FAM19A2, SCLT1, TGFB2, SCGB1A1, ASRGL1, ATP2C2, ANXA11, HLA-C, SFTPD
- health specialty
- pulmonology
- ICD-9-CM
- 496, 490-496.99
- ICPC 2 ID
- R95
- medical examination
- spirometry, arterial blood gas analysis
- possible treatment
- symptomatic treatment
- risk factor
- smoking
- topic's main category
- Category:Chronic obstructive pulmonary disease
Connected on Wikidata
Subject of
- COPD Awareness Month
- A Single-dose Study to Investigate the Effects of 4 Different Doses of Inhaled AZD8683 in Chronic Obstructive Pulmonary Disease (COPD) Patients
- Beneficial Effects of Quercetin in Chronic Obstructive Pulmonary Disease (COPD)
- Observational Study of Obstructive Lung Disease (NOVELTY)
- Investigation of Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Efficacy of Oral Danirixin in Symptomatic COPD Subjects With Mild to Moderate Airflow Limitation at Risk for Exacerbations
- Haemodynamic Effects of Apelin Agonists and Antagonists in Man in COPD With Raised Pulmonary Artery Pressures
- Epidemiology of Chronic Bronchitis in Patients With Chronic Obstructive Pulmonary Disease (COPD)
- Anti-ST2 (MSTT1041A) in COPD (COPD-ST2OP)
- Quality Control for Chronic Obstructive Pulmonary Disease
- Efficacy and Safety of Glycopyrronium/Formoterol Fumarate Fixed-dose Combination Relative to Umeclidinium/Vilanterol Fixed-dose Combination Over 24 Weeks in Patients With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
Nothing in the MetaHistoryBook collection references this item yet.